Dr Venkatesh on Liver Transplant for Wilson’s Disease: A Metabolic Cure
Dr Venkatesh BS, Transplant Surgeon at CareVue Health, posted on LinkedIn:
“Liver Transplant in Wilson’s Disease (WD): resetting copper metabolism and rewriting fate.
Wilson’s is one of those rare diseases where a transplant doesn’t just save a liver, it cures the metabolic defect. Yet, timing is everything. Miss it, and copper wins.
Indications
1. Acute Liver Failure (ALF): The “no-delay” zone.
• Encephalopathy + acute hepatic failure
• Rapid bilirubin rise (>20 mg/dL) + INR >2.0
• Modified King’s College criteria: AST:ALT > 2.2, bilirubin > 5.8 mg/dL, INR > 1.5
→ Without LT, mortality >90%.
2. Chronic WD / Decompensated Cirrhosis
• Ascites, variceal bleed, jaundice, encephalopathy despite optimal chelation
• MELD > 15-18 or Child-Pugh C
3. Neurological WD (the grey zone)
• Progressive neurological decline despite ≥6- 12 months of therapy
• 70- 85% improve post LT if done before irreversible damage
→ Early MDT (hepatology + neurology) is key.
The Challenges
Diagnosis can be deceptive, low ceruloplasmin may look “normal” in ALF, and hemolysis clouds the picture.
Selecting neuro-WD candidates demands balance: who will benefit neurologically versus who may not recover even with a new liver.
And perioperatively? Infection and cerebral edema are still the villains of early mortality. Meticulous critical care saves more lives than heroics.
Outcomes
• 1-year survival: 85-92%
• 5-year survival: ~80%
• Neurological improvement: ~75-85%
• Recurrence: None. WD is metabolically cured
• Main early causes of death: Sepsis, cerebral edema
The 2025 EASL-ERN update makes it simple:
Encephalopathy in WD-associated ALF = urgent transplant.
No encephalopathy? Use established prognostic tools (like King’s).
Translation: Don’t wait for “more evidence” when the copper crisis hits the brain.
Key Takeaway
When Wilson’s turns toxic, the clock ticks fast.
Transplantation doesn’t just restore hepatic function, it reprograms copper biology, often reversing neurological chaos and saving lives.
Copper may be ancient currency, but in the wrong hands, it bankrupts the liver. Thankfully, transplantation writes the ultimate balance sheet a metabolic reset and a new life.”

Stay informed with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS